According to a new market research report published
by Global Market Estimates, the Global Multiplex Assays Market is projected to
grow at a CAGR of 9.2% from 2023 to 2028.
The multiplex assays market is driven by factors
such as the increasing demand for faster and more efficient diagnostic
solutions fuels market growth. Multiplex assays allow for the simultaneous
detection and analysis of multiple analytes in a single sample, enabling
quicker and more comprehensive diagnoses.
Browse 147 Market Data Tables and 115 Figures spread through 163
Pages and in-depth TOC on “Global Multiplex Assays Market - Forecast to 2028’’ https://www.globalmarketestimates.com/market-report/multiplex-assays-market-3983
By Product & Service (Consumables, Instruments, and Software &
Services), By Type (Protein Multiplex Assays, Nucleic Acid Multiplex Assays,
and Cell-based Multiplex Assays), By Technology (Flow Cytometry, Fluorescence
Detection, Luminescence, Multiplex Real-Time PCR, Other Technologies), By
Application (Research & Development and Clinical Diagnostics), By End User
(Pharmaceutical & Biotechnology Companies, Hospitals & Research
Institutes, Reference Laboratories, Other End Users), and By Region (North
America, Asia Pacific, Central & South America, Europe, the Middle East and
Africa), Competitive Landscape, Company Market Share Analysis, and Competitor
Analysis)
Key Market Insights
·
As per the product
& service outlook, the consumables segment is expected to be the largest
segment in the global multiplex assays market from 2023 to 2028.
·
As per the type
outlook, the protein multiplex assays segment is expected to be the largest
segment in the global multiplex assays market from 2023 to 2028.
·
The Asia Pacific
region is analyzed to be the fastest-growing segment in the market.
·
North America
has the largest share in the market during the forecast period of 2023-2028.
·
Luminex
Corporation, Thermo Fisher Scientific Inc., Illumina, Inc, Bio-Rad
Laboratories, Inc, DiaSorin S.p.A., Becton, Dickinson and Company, Abcam plc.,
Seegene Inc., Merck KGaA, and Assay Genie among others, are some of the key
players in the global multiplex assays market.
Product
& Service Outlook (Revenue, USD Billion, 2023-2028)
·
Consumables
·
Instruments
·
Software &
Services
Type Outlook (Revenue, USD Billion, 2023-2028)
·
Protein Multiplex Assays
·
Nucleic Acid Multiplex
Assays
·
Cell-based Multiplex
Assays
Technology Outlook (Revenue,
USD Billion, 2023-2028)
·
Fluorescence Detection
·
Luminescence
·
Multiplex Real-Time PCR
·
Other Technologies
Application Outlook (Revenue,
USD Billion, 2023-2028)
·
Research &
Development
·
Clinical Diagnostics
End User Outlook (Revenue,
USD Billion, 2023-2028)
·
Pharmaceutical &
Biotechnology Companies
·
Hospitals & Research
Institutes
·
Reference Laboratories
·
Other End Users
By Regional Outlook
(Revenue, USD Billion, 2023-2028)
North America
Europe
Asia Pacific
Central
& South America
Middle
East & Africa
Contact:
Yash Jain
Director-
Global Accounts & Strategic Advisory
Email
address: yash.jain@globalmarketestimates.com
Phone
Number: +1 6026667238
Website:
www.globalmarketestimates.com